Action
Administer cryoprecipitate (dosing dependent on patient body weight and fibrinogen levels)
Background
Acute coagulopathy in the postpartum period can be caused by massive blood loss, placental abruption, or amniotic fluid embolism. Placental abruption is accompanied by DIC and hypofibrinogenemia (low fibrin levels). Blood loss into the myometrium can result in uterine atony as well. Patients typically present with vaginal bleeding, uterine contractions, and pelvic pain. Amniotic fluid embolism is rare but is also associated with significant DIC and postpartum hemorrhage.
‣
- United States Centers for Disease Control and Prevention. Preventing Pregnancy-Related Deaths. Accessed September 1, 2021. (Informational website)
- United States Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. Accessed September 1, 2021. (Surveillance data)
- The Joint Commission. Provision of care, treatment, and services standards for maternal safety. R3 Report: Requirement, Rationale, Reference. 2019(24):1-6. (Rationale statement)
- Practice Bulletin No. 183: postpartum hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186. (Practice guideline)
- World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Accessed September 1, 2021. (Practice guideline)
- Quantitative blood loss in obstetric hemorrhage: ACOG Committee Opinion Summary, Number 794. Obstet Gynecol. 2019;134(6):1368-1369. (Practice guideline)
- Creanga AA, Berg CJ, Ko JY, et al. Maternal mortality and morbidity in the United States: where are we now? J Womens Health (Larchmt). 2014;23(1):3-9. (Review)
- Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician. 2007;75(6):875-882. (Practice recommendations)
- Kandeel M, Sanad Z, Ellakwa H, et al. Management of postpartum hemorrhage with intrauterine balloon tamponade using a condom catheter in an Egyptian setting. Int J Gynaecol Obstet. 2016;135(3):272-275. (Prospective observational study; 151 patients)
- Darwish AM, Abdallah MM, Shaaban OM, et al. Bakri balloon versus condom-loaded Foley’s catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018;31(6):747-753. (Randomized controlled trial; 66 patients)
- Rathore AM, Gupta S, Manaktala U, et al. Uterine tamponade using condom catheter balloon in the management of non-traumatic postpartum hemorrhage. J Obstet Gynaecol Res. 2012;38(9):1162-1167. (Prospective study; 18 patients)
- Tindell K, Garfinkel R, Abu-Haydar E, et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG. 2013;120(1):5-14. (Literature review; 13 studies, 241 patients)
- Tranexamic Acid - Drug Summary. Prescribers' Digital Reference. Accessed September 1, 2021. (Medication package insert)
- Gestational hypertension and pre-eclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260. (Practice guideline)
- Vermillion ST, Scardo JA, Newman RB, et al. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999;181(4):858-861. (Randomized double-blind trial; 50 patients)
- Raheem IA, Saaid R, Omar SZ, et al. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012;119(1):78-85. (Randomized double-blind trial; 50 patients)
- Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics. 2016;138(3):e20160731. (Retrospective cohort; 10,585 patients)
- Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with pre-eclampsia. Am J Obstet Gynecol. 2005;193(1):153-163. (Retrospective chart review; 377 patients)
